EP1631293A2

Compounds, formulations, and methods for treating or preventing rosacea

Abstract

This record has no abstract on file.

EP1631293A2, drawing sheet 1 — Sheet 1 of 24

Term

Term ended

Projected expiry passed 26 May 2024, 2.3 years ago.

24 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10
Sheet 11
Sheet 12
Sheet 13
Sheet 14
Sheet 15
Sheet 16
Sheet 17
Sheet 18
Sheet 19
Sheet 20
Sheet 21
Sheet 22
Sheet 23
Sheet 24

Every citation, both ways

Citations
Document	Relation	Office	Cited during
WO2005010025A2	Cites	World Intellectual Property Organization (WIPO)	Search report
WO2005060948A1	Cites	World Intellectual Property Organization (WIPO)	Opposition
US6534048B1	Cites	United States of America	Opposition

166 members in 27 offices

This recordMember, by publication date17 more offices are in the list below

Members166

Family members, oldest first
Document	Office	Kind
US2004242588A1	United States of America	A1	2004-12-02
AU2004242967A1	Australia	A1	2004-12-09
CA2530938A1	Canada	A1	2004-12-09
WO2004105703A2	World Intellectual Property Organization (WIPO)	A2	2004-12-09
WO2004105703A3	World Intellectual Property Organization (WIPO)	A3	2005-03-17
AU2005247467A1	Australia	A1	2005-12-08
CA2567401A1	Canada	A1	2005-12-08
CA2824612A1	Canada	A1	2005-12-08
WO2005115395A2	World Intellectual Property Organization (WIPO)	A2	2005-12-08
US2005276830A1	United States of America	A1	2005-12-15
NO20056104L	Norway	L	2006-02-03
EP1631293A2This record	European Patent Office (EPO)	A2	2006-03-08
MXPA05014107A	Mexico	A	2006-03-17
US2006171974A1	United States of America	A1	2006-08-03
HK1084591A	Hong Kong, China	A	2006-08-04
HK1084591A1	Hong Kong, China	A1	2006-08-04
CN1829518A	China	A	2006-09-06
US2006264515A1	United States of America	A1	2006-11-23
EP1761266A2	European Patent Office (EPO)	A2	2007-03-14
KR20070032716A	Republic of Korea	A	2007-03-22
MXPA06013649A	Mexico	A	2007-07-09
BRPI0511519A	Brazil	A	2007-12-26
JP2008500356A	Japan	A	2008-01-10
US7439241B2	United States of America	B2	2008-10-21
CN101380321A	China	A	2009-03-11
NZ544300A	New Zealand	A	2009-03-31
WO2005115395A3	World Intellectual Property Organization (WIPO)	A3	2009-04-09
CN101426502A	China	A	2009-05-06
EP1631293A4	European Patent Office (EPO)	A4	2009-05-06
AU2004242967B2	Australia	B2	2009-05-28
EP1761266A4	European Patent Office (EPO)	A4	2009-11-11
US2010021402A1	United States of America	A1	2010-01-28
US2010130502A1	United States of America	A1	2010-05-27
CN101816793A	China	A	2010-09-01
CN1829518B	China	B	2010-09-08
US2010227867A1	United States of America	A1	2010-09-09
US7838563B2	United States of America	B2	2010-11-23
NZ552325A	New Zealand	A	2010-11-26
AU2005247467B2	Australia	B2	2010-12-02
CA2792646A1	Canada	A1	2011-09-29
WO2011117377A2	World Intellectual Property Organization (WIPO)	A2	2011-09-29
EP1631293B1	European Patent Office (EPO)	B1	2011-10-26
AT530185T	Austria	T	2011-11-15
ATE530185T1	Austria	T1	2011-11-15
EP2388007A1	European Patent Office (EPO)	A1	2011-11-23
US2011286944A1	United States of America	A1	2011-11-24
US2011288096A1	United States of America	A1	2011-11-24
CA2530938C	Canada	C	2011-12-13
PT1631293E	Portugal	E	2012-02-01
DK1631293T3	Denmark	T3	2012-02-13
SI1631293T1	Slovenia	T1	2012-02-29
ES2376172T3	Spain	T3	2012-03-09
PL1631293T3	Poland	T3	2012-03-30
JP2012072176A	Japan	A	2012-04-12
JP4955543B2	Japan	B2	2012-06-20
US8231885B2	United States of America	B2	2012-07-31
EP2481412A1	European Patent Office (EPO)	A1	2012-08-01
CN101816793B	China	B	2012-08-15
US2012214816A1	United States of America	A1	2012-08-23
HK1164126A	Hong Kong, China	A	2012-09-21
HK1164126A1	Hong Kong, China	A1	2012-09-21
AU2011231543A1	Australia	A1	2012-09-27
MX2012010824A	Mexico	A	2012-10-10
CN102743380A	China	A	2012-10-24
US2012277241A1	United States of America	A1	2012-11-01
KR20130002338A	Republic of Korea	A	2013-01-07
WO2011117377A3	World Intellectual Property Organization (WIPO)	A3	2013-01-10
EP2552449A2	European Patent Office (EPO)	A2	2013-02-06
US2013071489A1	United States of America	A1	2013-03-21
IL172612A	Israel	A	2013-03-24
CN101380321B	China	B	2013-03-27
US8410102B2	United States of America	B2	2013-04-02
KR101257046B1	Republic of Korea	B1	2013-04-22
US8426410B2	United States of America	B2	2013-04-23
EP1761266B1	European Patent Office (EPO)	B1	2013-05-08
PT1761266E	Portugal	E	2013-06-04
JP2013523611A	Japan	A	2013-06-17
NO333468B1	Norway	B1	2013-06-17
US2013172358A1	United States of America	A1	2013-07-04
US2013172359A1	United States of America	A1	2013-07-04
US2013197003A1	United States of America	A1	2013-08-01
DK1761266T3	Denmark	T3	2013-08-05
US8513247B2	United States of America	B2	2013-08-20
US8513249B2	United States of America	B2	2013-08-20
SI1761266T1	Slovenia	T1	2013-08-30
CN103298472A	China	A	2013-09-11
PL1761266T3	Poland	T3	2013-09-30
ES2424644T3	Spain	T3	2013-10-07
US8557817B2	United States of America	B2	2013-10-15
CA2567401C	Canada	C	2013-11-12
US8586586B2	United States of America	B2	2013-11-19
US2014080836A1	United States of America	A1	2014-03-20
US2014094469A1	United States of America	A1	2014-04-03
RU2012145616A	Russian Federation	A	2014-05-10
RU2519676C1	Russian Federation	C1	2014-06-20
JP5547705B2	Japan	B2	2014-07-16
FR14C0056I1	France	I1	2014-08-22
EP1631293B2	European Patent Office (EPO)	B2	2014-10-08
US8859551B2	United States of America	B2	2014-10-14
EP2815748A1	European Patent Office (EPO)	A1	2014-12-24

Showing 100 of 166

163 legal events, as 24 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2025-03-12	Supplementary protection certificate lapsedLapsedSPCL	SPCL	IE
2025-01-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2025-01-24	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2025-01-15	Lapse of an spcLapsedSPCL	SPCL	AT
2025-01-07	Supplementary protection certificate lapsed or expiredExpiredSPCL	SPCL	FR
2024-12-30	Supplementary protection certificate deletionSPCL	SPCL	CH
2024-12-16	Supplementary protection certificate (spc) lapsedLapsedCTFL	CTFL	DK
2024-12-03	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119	R119	DE
2024-12-03	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee [spc]WithdrawnS119	S119	DE
2024-09-02	Supplementary protection certificate rejectedSPCD	SPCD	BE
2024-08-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-08-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-23	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-22	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-15	ExpiryMK07	MK07	AT
2024-07-08	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-05	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-03	Patent expiredExpiredMK9A	MK9A	IE
2024-07-02	Ep patent has lapsedLapsedEUG	EUG	SE
2024-06-19	Patent expiredExpiredMK4A	MK4A	SK
2024-06-19	Patent expired after termination of 20 yearsExpiredPE20	PE20	GB
2024-06-04	Patent expired because of reaching the maximum lifetime of a patentExpiredMK	MK	BE
2024-05-31	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2024-05-31	Patent ceasedCeasedPL	PL	CH
2024-05-29	Patent expired because of reaching the maximum lifetime of a patentExpiredMK	MK	NL
2024-05-27	Ep patent expiredExpiredEUP	EUP	DK
2024-05-26	Expiry of rightR071	R071	DE
2023-12-19	Change of representative [supplementary protection certificate]SP82	SP82	DE
2023-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-09-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-06-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-03-31	Certificates - modification new representativeSPCN	SPCN	CH
2021-11-17	Application to withdraw or offer to surrender a supplementary protection certificateCTFW	CTFW	GB
2021-09-10	Withdrawal, rejection or dismissal of a supplementary protection certificateSPCL	SPCL	FI
2020-10-21	Supplementary protection certificate application rejectedSPCD	SPCD	NL
2019-01-22	Supplementary protection certificate grantedGrantedSPCG	SPCG	RO
2018-08-24	Supplementary protection certificate filedSPCF	SPCF	BE
2018-04-11	Fee paymentPLFP	PLFP	FR
2017-10-30	Grant of supplementary protection certificateFG4S	FG4S	HU
2017-04-13	Fee paymentPLFP	PLFP	FR
2017-02-28	Supplementary protection certificate grantedGrantedSPCG	SPCG	CH
2017-01-20	Other action affecting the existence or the validity of an industrial property rightAV	AV	FR
2016-12-23	Granted supplementary protection certificate (spc) for medicine (eec regulation of 18 june 1992)GrantedCT	CT	FR
2016-12-14	Supplementary protection certificate grantedGrantedSPCG	SPCG	IE
2016-09-13	Supplementary protection certificate grantedGrantedR069	R069	DE
2016-09-13	Supplementary protection certificate grantedGrantedR069	R069	DE
2016-08-05	Decision to grant supplementary protection certificate by patent divisionR067	R067	DE
2016-08-05	Decision to grant supplementary protection certificate by patent divisionR067	R067	DE
2016-04-12	Fee paymentPLFP	PLFP	FR
2015-12-03	Grant of an spcSPCG	SPCG	SK
2015-11-11	Application for a supplementary protection certificateSPCF	SPCF	NL
2015-11-02	Supplementary protection certificateCCP	CCP	LU
2015-10-15	Spc grantedGrantedFG1Y	FG1Y	EE
2015-05-15	New agentNV	NV	CH
2015-05-15	CorrectionDER VERTRETER WURDE IRRTUEMLICH GELOESCHTPK	PK	CH
2015-05-05	Translation of an amended european patent specificationT5	T5	SK
2015-04-30	Translation of modified ep patentT5	T5	PL
2015-03-16	Amendment in the specificationLD4A	LD4A	EE
2015-03-11	Ep patent validated in greeceEP	EP	GR
2015-03-10	Supplementary protection certificate grantedGrantedSPCG	SPCG	SE
2015-01-30	Supplementary protection certificate filedPRODUCT NAME: BRIMONIDIN; REGISTRATION NO/DATE: SWISSMEDIC 65180 21.11.2014SPCF	SPCF	CH
2015-01-14	Translation filed for an european patent granted for nl, confirming art. 52 par. 1 or 6 of the patents act 1995GrantedT3	T3	NL
2015-01-12	Amended ep patent with danish claimsT4	T4	DK
2015-01-08	Patent modifiedDC2A	DC2A	ES
2014-12-30	Ep patent has been republished in amended form after opposition at epoOppositionRPEO	RPEO	SE
2014-11-13	Epo decision maintaining patent in amended form now finalR102	R102	DE
2014-11-04	Filing of an spcSPCF	SPCF	SK
2014-10-15	Spc filedAA1Y	AA1Y	EE
2014-10-15	Maintained in amend formAELC	AELC	CH

Showing 100 of 163

Compounds, formulations, and methods for treating or preventing rosacea

Abstract

Term

Members166

Over the term

Events

Numbers

Titles3

Classification

Designated states33